{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:10:07Z","timestamp":1709266207266},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>A s\u00edndrome de Prader-Willi (PWS), com preval\u00eancia de 60:1.000.000, \u00e9 o resultado da perda de parte do cromossomo 15 paterno, em raz\u00e3o da dele\u00e7\u00e3o em 56% dos casos, dissomia uniparental materna em 24% dos casos, ou por causa da metila\u00e7\u00e3o, fen\u00f4meno epigen\u00e9tico, em 18% dos casos. O quadro cl\u00ednico inicia-se com profunda hipotonia que, especialmente no primeiro ano de vida, torna dif\u00edcil a alimenta\u00e7\u00e3o da crian\u00e7a. Conforme melhora a hipotonia, nos primeiros dois anos, por volta do quarto ano de vida, um apetite insaci\u00e1vel adv\u00e9m, o que leva tais crian\u00e7as \u00e0 obesidade extrema, com hipoventila\u00e7\u00e3o alveolar que p\u00f5e em risco sua sobreviv\u00eancia. Dessa forma, paradoxalmente, a PWS amea\u00e7a a vida dos pacientes, em um primeiro momento, por inani\u00e7\u00e3o e, em uma fase posterior, pelo excesso de peso. O uso de horm\u00f4nio de crescimento (hrGH) nessas crian\u00e7as tem por objetivo prim\u00e1rio a mudan\u00e7a da composi\u00e7\u00e3o corp\u00f3rea e a melhora da atividade f\u00edsica e da qualidade de vida. Por outro lado, muitos pacientes com PWS s\u00e3o, de fato, deficientes em GH, ocorrendo melhora no padr\u00e3o de crescimento com o tratamento. Tem-se de ser cuidadoso, no entanto, ao iniciar o tratamento com hrGH, com zelosa avalia\u00e7\u00e3o da apn\u00e9ia do sono (polissonografia) e da permeabilidade das vias a\u00e9reas, tendo em vista que o tratamento com hrGH pode piorar o padr\u00e3o respirat\u00f3rio em alguns pacientes.<\/jats:p>","DOI":"10.1590\/s0004-27302008000500015","type":"journal-article","created":{"date-parts":[[2008,9,29]],"date-time":"2008-09-29T14:04:10Z","timestamp":1222697050000},"page":"833-838","source":"Crossref","is-referenced-by-count":3,"title":["Uso de horm\u00f4nio de crescimento na s\u00edndrome de Prader-Willi"],"prefix":"10.1590","volume":"52","author":[{"given":"Durval","family":"Damiani","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","first-page":"1260","article-title":"Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophernie nach myotonieartigem zustand im neugeborenenalter","volume":"86","author":"Prader A","year":"1956","journal-title":"Schweiz Med Wochenschr","ISSN":"http:\/\/id.crossref.org\/issn\/0036-7672","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/jmg.32.2.88","article-title":"DNA methylation based testing of 450 patients suspected of having Prader-Willi syndrome","volume":"32","author":"Gillessen-Kaesbach G","year":"1995","journal-title":"J Med Genet."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.91.2.398","article-title":"Prader-Willi syndrome: consensus diagnostic criteria","volume":"91","author":"Holm V","year":"1993","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"issue":"7","key":"ref4","first-page":"861","article-title":"The Italian national survey for Prader-Willi syndrome: an epidemiologic study","volume":"146","author":"Stafler P","year":"2008","journal-title":"Am J Med Genet."},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1590\/S0004-27302007000100015","article-title":"S\u00edndrome de Prader-Willi: aspectos metab\u00f3licos associados ao tratamento com horm\u00f4nio de crescimento","volume":"51","author":"Kuo JY","year":"2007","journal-title":"Arq Bras Endocrinol Metab."},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1007\/s00431-008-0679-0","article-title":"Central precocious puberty and growth hormone deficiency in a boy with Prader-Willi syndrome","author":"Crin\u00f2 A","year":"2008","journal-title":"Eur J Pediatr","ISSN":"http:\/\/id.crossref.org\/issn\/0340-6199","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00024677-200605040-00003","article-title":"Somatropin therapy for children with Prader-Willi syndrome: guidelines for use","volume":"5","author":"Lindgren AC","year":"2006","journal-title":"Treat Endocrinol."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1515\/JPEM.2006.19.7.911","article-title":"Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome","volume":"19","author":"Krochik AG","year":"2006","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1210\/jc.2006-2241","article-title":"Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy","volume":"92","author":"Festen DA","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"ref10","first-page":"1297","article-title":"Growth hormone therapy for Prader-Willi syndrome: a critical appraisal","volume":"17","author":"Allen DB","year":"2004","journal-title":"J Pediatr Endocrinol Metab."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1515\/jpem-2001-0805","article-title":"Prader-Willi syndrome: how does growth hormone affect body composition and physical function?","volume":"14","author":"Carrel AL","year":"2001","journal-title":"J Pediatr Endocrinol Metab."},{"key":"ref12","first-page":"853","article-title":"Standards for selected anthropometric measurements in Prader-Willi syndrome","volume":"88","author":"Butler MG","year":"1991","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jmg.34.11.917","article-title":"Prader-Willi syndrome","volume":"34","author":"Cassidy SB","year":"1997","journal-title":"J Med Genet."},{"key":"ref14","first-page":"S87","article-title":"Growth hormone and adipocyte function in obesity","volume":"53","author":"Nam SY","year":"2000","journal-title":"Horm Res."},{"key":"ref15","first-page":"149","article-title":"Ghrelin and feedback systems","volume":"77","author":"Nonogaki K","year":"2008","journal-title":"Bitam Horm."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2006.05.010","article-title":"Growth hormone deficiency, low lwvels of adiponectin, and unfavorable plasma lipid and lipoproteins","volume":"149","author":"Lanes R","year":"2006","journal-title":"J Pediatr."},{"key":"ref17","first-page":"4516","article-title":"Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children","volume":"84","author":"Johannsson G","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1210\/jc.2005-0981","article-title":"Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study","volume":"91","author":"Salerno M","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2788.2006.00878.x","article-title":"Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study","volume":"51","author":"Bertella L","year":"2007","journal-title":"J Intellect Disabil Res."},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/adc.2007.126334","article-title":"Prader-Willi syndrome: who can have growth hormone?","volume":"93","author":"Stafler P","year":"2008","journal-title":"Arch Dis Child."},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2008.03228.x","article-title":"Randomized controlled growth hormone trial: effects on anthropometry, body composition, and body proportion in a large group of children with Prader-Willi syndrome","author":"Festen DA","year":"2008","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1515\/JPEM.2007.20.4.491","article-title":"Nutrient intake and body composition variables in Prader-Willi syndrome: of growth hormone supplementation and genetic subtype","volume":"20","author":"Galassetti P","year":"2007","journal-title":"J Pediatr Endocrinol Metab."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajmg.a.31468","article-title":"Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits","volume":"143","author":"Meyers SE","year":"2007","journal-title":"Am J Med Genet."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/ajmg.a.31295","article-title":"Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome","volume":"140","author":"Nagai T","year":"2006","journal-title":"Am J Med Genet."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/08035250510027110","article-title":"Death in two female Prader-Willi syndrome patients during the early phase of growth hormone treatment","volume":"94","author":"Riedl S","year":"2005","journal-title":"Acta Paediatr."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF03347245","article-title":"Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Death during GH therapy in children with Prader-Willi syndrome: description of two new cases","volume":"28","author":"Grugni G","year":"2005","journal-title":"J Endocrinol Invest."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v52n5\/15.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T03:40:27Z","timestamp":1709264427000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302008000500015&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0004-27302008000500015"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302008000500015","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}